drugset / Trial / NCT01471808

Summary

The purpose of this study is to investigate and evaluate the effects of different oral antihyperglycaemic agents combined with short-term continuous subcutaneous insulin infusion(CSII)(1.CSII alone; 2.metformin and pioglitazone combined with CSII; 3. sitagliptin combined with CSII) on long-term glycemic control and β-cell function in newly diagnosed type 2 diabetic patients.

Timeline

Start
2011-10
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 1.5 g Oral
Comparator Pioglitazone Small molecule 30 mg Oral
Comparator Sitagliptin Small molecule 100 mg Oral